Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Plasma cell senescence in relapsed multiple myeloma revealed by integrated single-cell RNA-seq analysis

Gabriel Alvares Borges, Angelo Guilatco, Sofia Arbelaez, Chen Wu, Neal Sannuli, Ying Li, Taxiarchis Kourelis, Wilson Gonsalves, Yi Lin, Megan Weivoda

Blood (2025) 146 (Supplement 1): 2166.

https://doi.org/10.1182/blood-2025-2166

Published: 2025

Journal Articles

Phase 1/2 studies of DZD8586 in CLL/SLL patients after COVALENT and non-COVALENT BTK inhibitors and BTK degraders – extended follow-up report

Blood (2025) 146 (Supplement 1): 3889.

https://doi.org/10.1182/blood-2025-3889

Published: 2025

Journal Articles

The prospect of high-dose vitamin c in improving early survival in patients with hemophagocytic lymphohistiocytosis

Jiayi Ren, Wu Shishuang, Kai Qing, Jiong Hu, JUN Zhu, Yingying WANG, Ying-Li Wu, Kai Xue

Blood (2025) 146 (Supplement 1): 6550.

https://doi.org/10.1182/blood-2025-6550

Published: 2025

Journal Articles

Characterization of antecedent clonal hematopoiesis (CH) mutations in lymphoid and plasma cell neoplasms

Pinkal Desai, Zichan Li, Ying Li, Nuria Mencia-Trinchant, Kathryn Gorski, Wodan Ling, Ellen Ritchie, Michael Samuel, Jonathan Canaani, Michal Bar-Natan, Olivier Elemento, Lesley Tinker, Wendy Cozen, Monica Guzman, Andrea Sboner, Gail Roboz

Blood (2025) 146 (Supplement 1): 1399.

https://doi.org/10.1182/blood-2025-1399

Published: 2025

Journal Articles

Genotype-guided comparison of ven-HMA versus intensive chemotherapy in newly diagnosed intermediate-risk AML: A multicenter real-world study

XIN CHEN, yuhan yan, Qian Cheng, yishu tang, ying Li, han xiao, erhua wang, jian zhang, Liwen Wang, qin zhang, Rong He, Fangping Chen, Xin Li

Blood (2025) 146 (Supplement 1): 3452.

https://doi.org/10.1182/blood-2025-3452

Published: 2025

Journal Articles

Immune reconstitution following memory T-cell add back and prophylactic blinatumomab post TCRαβ/CD19-depleted haploidentical transplantation in pediatric patients with high-risk acute leukemia

Shruthi Suryaprakash, Ying Li, Scott Perry, Deanna Langfitt, Dinesh Keerthi, Jean-Yves Metais, Stephen Gottschalk, Brandon Triplett, Swati Naik

Blood (2025) 146 (Supplement 1): 273.

https://doi.org/10.1182/blood-2025-273

Published: 2025

Journal Articles

Potential biomarkers and mechanisms in central nervous system involvement of KMT2A rearranged b-ALL: Insights from Patient-derived xenograft models

Der-Shiun Wang, Jhih-Yu Pan, Yu-Chun Liao, Chia-Lun Hong, Chih- Hsiang Yu, Ying-Hui Su, Huei-Ying Li, Shu-Wei Chou, Meng-Yao Lu, Hsiu-Hao Chang, Shiann-Tang Jou, Wen-Chien Chou, Yung-Li Yang, Shu-Wha Lin

Blood (2025) 146 (Supplement 1): 3256.

https://doi.org/10.1182/blood-2025-3256

Published: 2025

Journal Articles

TDI01 in the treatment of moderate to severe chronic graft-versus-host disease: Updated results from a multicenter, OPEN-label phase IB/II study (An Update)

Xiaojun Huang, Xiao-Dong Mo, Xuejun Zhang, Rong Guo, Er-Lie Jiang, Jiejing Qian, Xiaoyu Zhu, Jia Wei, Shun-Qing Wang, Zhongming Zhang, Zhuogang Liu, Yuxian Huang, Zhiguo Wang, Xiaoyuan Dong, Hai Yi, Ying Li

Blood (2025) 146 (Supplement 1): 4229.

https://doi.org/10.1182/blood-2025-4229

Published: 2025

Journal Articles

Primary analysis of a multicenter, open-label, phase 2 study of sonrotoclax (BGB-11417) monotherapy in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)

Blood (2025) 146 (Supplement 1): 5666.

https://doi.org/10.1182/blood-2025-5666

Published: 2025

Journal Articles

Metabolic pathway signatures unpinning response to CD19 CAR T-cell therapy in aggressive B-cell non-Hodgkin's lymphoma

Blood (2025) 146 (Supplement 1): 5894.

https://doi.org/10.1182/blood-2025-5894

Published: 2025

Journal Articles

N-homocysteinylation of β-arrestins biases GPCR signaling and promotes platelet activation

Blood (2025) 145 (20): 2374–2389.

https://doi.org/10.1182/blood.2024025593

Published: 2025

Includes: Supplemental data

Journal Articles

Memory T-Cell Add Back and Prophylactic blinatumomab Post Tcrαβ Depleted Haploidentical Transplantation Results in Promising Outcomes in Pediatric Patients with High-Risk Acute Leukemia

Blood (2024) 144 (Supplement 1): 383.

https://doi.org/10.1182/blood-2024-208547

Published: 2024

Journal Articles

A First-in-Human Study of CT0590, a Triple Knock-out, Allogeneic CAR T-Cell Therapy Targeting BCMA and NKG2A, in Subjects with Relapsed/Refractory Multiple Myeloma

Chengcheng Fu, Lingzhi Yan, Weiqin Yao, Jingjing Shang, Song Jin, Shuang Yan, Fang Tang, Ziling Zhu, Depei Wu, Ying Li, Nishanthan Rajakumaraswamy, Wei Zheng, Hua Jiang, Zhaohui Liao, Zonghai Li

Blood (2024) 144 (Supplement 1): 4843.

https://doi.org/10.1182/blood-2024-204401

Published: 2024

Journal Articles

Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)

Qian Cheng, JingWen Tan, Rui Liu, Liqing Kang, Hongjia Zhu, Yi Zhang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Rong He, Xiaoyan Lou, Nan Xu, Wei Wang, Zhou Yu, Minghao Li, Hongfei Gu, Lei Yu, Xin Li

Blood (2024) 144 (Supplement 1): 3447.

https://doi.org/10.1182/blood-2024-200516

Published: 2024

Journal Articles

CD123-CAR T Cells Manufactured in the Presence of Dasatinib Induce High Grade CRS and/or IEC-HS without Improving Efficacy in Pediatric Patients with Recurrent/Refractory Leukemia

Blood (2024) 144 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2024-208795

Published: 2024

Journal Articles

Umbilical Cord Blood Stem Cells As Third-Party Adjuvant Infusion in Human Leukocyte Antigen Antibody-Positive Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Yujie Jiang, Yuying Wang, Dai Yuan, Xiaosheng Fang, Huiting Qu, Lingyan Zhang, Ying Li, Xin Wang

Blood (2023) 142 (Supplement 1): 6911.

https://doi.org/10.1182/blood-2023-182905

Published: 2023

Journal Articles

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

Blood (2023) 141 (25): 3078–3090.

https://doi.org/10.1182/blood.2022015830

Published: 2023

Includes: Supplemental data

Journal Articles

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Blood (2022) 140 (Supplement 1): 9544–9545.

https://doi.org/10.1182/blood-2022-169274

Published: 2022

Journal Articles

Establishment of Patient-Derived Xenograft (PDX) Zebrafish Model of Multiple Myeloma and Its Application in Drug Screening

Zhen Yu, Ying Li, Kefei Wang, Lu Wang, Lugui Qiu, Mu Hao

Blood (2022) 140 (Supplement 1): 12524.

https://doi.org/10.1182/blood-2022-156995

Published: 2022

Journal Articles

Global Burden, Risk Factors, and Trends of Non-Hodgkin Lymphoma in 2020 and Projections to 2040: A Population-Based Study

Yurou Chu, Yingyue Liu, Xiaosheng Fang, Yujie Jiang, Mei Ding, Xueling Ge, Dai Yuan, Kang Lu, Peipei Li, Ying Li, Hongzhi Xu, Juan Fan, Xiangxiang Zhou, Xin Wang

Blood (2022) 140 (Supplement 1): 3844–3845.

https://doi.org/10.1182/blood-2022-168779

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Plasma cell senescence in relapsed multiple myeloma revealed by integrated single-cell RNA-seq analysis

Phase 1/2 studies of DZD8586 in CLL/SLL patients after COVALENT and non-COVALENT BTK inhibitors and BTK degraders – extended follow-up report

The prospect of high-dose vitamin c in improving early survival in patients with hemophagocytic lymphohistiocytosis

Characterization of antecedent clonal hematopoiesis (CH) mutations in lymphoid and plasma cell neoplasms

Genotype-guided comparison of ven-HMA versus intensive chemotherapy in newly diagnosed intermediate-risk AML: A multicenter real-world study

Immune reconstitution following memory T-cell add back and prophylactic blinatumomab post TCRαβ/CD19-depleted haploidentical transplantation in pediatric patients with high-risk acute leukemia

Potential biomarkers and mechanisms in central nervous system involvement of KMT2A rearranged b-ALL: Insights from Patient-derived xenograft models

TDI01 in the treatment of moderate to severe chronic graft-versus-host disease: Updated results from a multicenter, OPEN-label phase IB/II study (An Update)

Primary analysis of a multicenter, open-label, phase 2 study of sonrotoclax (BGB-11417) monotherapy in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)

Metabolic pathway signatures unpinning response to CD19 CAR T-cell therapy in aggressive B-cell non-Hodgkin's lymphoma

N-homocysteinylation of β-arrestins biases GPCR signaling and promotes platelet activation

Memory T-Cell Add Back and Prophylactic blinatumomab Post Tcrαβ Depleted Haploidentical Transplantation Results in Promising Outcomes in Pediatric Patients with High-Risk Acute Leukemia

A First-in-Human Study of CT0590, a Triple Knock-out, Allogeneic CAR T-Cell Therapy Targeting BCMA and NKG2A, in Subjects with Relapsed/Refractory Multiple Myeloma

Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)

CD123-CAR T Cells Manufactured in the Presence of Dasatinib Induce High Grade CRS and/or IEC-HS without Improving Efficacy in Pediatric Patients with Recurrent/Refractory Leukemia

Umbilical Cord Blood Stem Cells As Third-Party Adjuvant Infusion in Human Leukocyte Antigen Antibody-Positive Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Establishment of Patient-Derived Xenograft (PDX) Zebrafish Model of Multiple Myeloma and Its Application in Drug Screening

Global Burden, Risk Factors, and Trends of Non-Hodgkin Lymphoma in 2020 and Projections to 2040: A Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only